Skip to main content
Caplight Logo









Transpire Bio Inc.

Transpire Bio Inc.

Private
Sunrise, FloridaHealthcare & Life Scienceshttps://www.transpirebio.com/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Transpire Bio Inc. is a clinical-stage biopharmaceutical company that develops inhaled therapeutics and proprietary drug delivery platforms for respiratory and systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

inhalation drug deliverydrug-device combinationdry powder inhalersoft-mist inhalercomplex generic drugsbiopharmaceuticalANDAabbreviated new drug applicationrespiratory medicineinhalation therapydrug out-licensingpharma co-developmentinhaler techrespiratory techdrug delivery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Transpire Bio Inc. Comparables

Compare Transpire Bio Inc. with similar companies based on industry and business-model similarity.

Transpire Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
invoX Pharma
82%
Iconovo AB
80%
Chance Pharmaceuticals
78%

Transpire Bio Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Grew 16% QoQ, from 109 to 126 employees.

  • May 17, 2026

    Monthly visitors grew 107% MoM, reaching 3.2K.

Recent news

Latest coverage and updates

  • is_developingAug 11, 2026

    Transpire Bio Inc. is developing pipeline of innovative inhalation medicines for Idiopathic Pulmonary Fibrosis.

  • attends_eventJun 18, 2026

    Transpire Bio Inc attended event 2026 BIO International Convention on Jun 18th '26.

Transpire Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Transpire Bio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Transpire Bio Inc.'s valuation, stock price, and market status.

Is Transpire Bio Inc. a public or private company?

Transpire Bio Inc. is a private company.

What is the current stock price of Transpire Bio Inc.?

Transpire Bio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Transpire Bio Inc. worth (valuation)?

Valuation information for Transpire Bio Inc. is not publicly available.

Can I buy Transpire Bio Inc. stock?

Transpire Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Transpire Bio Inc.'s last funding round?

Funding round information for Transpire Bio Inc. is not publicly available.

Who are the main investors in Transpire Bio Inc.?

Investor information for Transpire Bio Inc. is not publicly disclosed.

Will Transpire Bio Inc. IPO soon?

No public IPO plans have been announced for Transpire Bio Inc..

How can I track Transpire Bio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Transpire Bio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSunrise, Florida
Employee Range87
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?